Results 61 to 70 of about 3,909 (222)
Background The use of terlipressin, a long-acting synthetic analog of vasopressin, is associated with reduction in cardiac output and oxygen delivery. The present study was designed to determine whether dobutamine may reverse the terlipressin-induced depression in central venous oxygen saturation (SvO 2 ) in patients with catecholamine-dependent ...
Tarek Shabana+3 more
openaire +2 more sources
Terlipressin-induced ischaemic skin necrosis
Terlipressin is a commonly used drug in hepatology practice for the two most serious complications of cirrhosis, that is, acute oesophageal variceal bleed and hepatorenal syndrome. Acute-on-chronic liver failure (ACLF) is a medical emergency and is frequently associated with acute kidney injury (AKI).
Anand V Kulkarni+3 more
openaire +3 more sources
The retrospective cohort study is the first to compare OPAL with Prometheus and hemodialysis for adult ACLF patients. Both extracorporeal liver support systems were comparably effective with regard to the reduction of bilirubin and creatinine levels surpassing the effects seen in hemodialysis. We recognized improvements in clinical scoring, such as the
Justa Friebus‐Kardash+8 more
wiley +1 more source
The “dark” side of terlipressin: a case report of ischemic skin necrosis and review of literature
Background Terlipressin is a commonly used drug in cirrhotic patients with acute variceal bleed (AVB) due to its vasoconstrictor effects. Ischemic complications are uncommon adverse events associated with worse outcomes.
Arpit Shastri+4 more
doaj +1 more source
Abstract Aim Hepatorenal syndrome‐induced acute kidney injury (AKI) comprises AKI and liver cirrhosis (LC) and is a risk factor for poor prognoses of patients with LC. Decreased a disintegrin‐like metalloproteinase with thrombospondin type 1 motif 13 (ADAMTS13) activity and increased von Willebrand factor (vWF) antigen levels are associated with LC ...
Masayoshi Takami+9 more
wiley +1 more source
Background and Aim To explore the risk factors of hyponatremia caused by terlipressin. Methods Forty‐four patients with acute variceal bleeding treated with terlipressin from December 2016 to December 2018 were analyzed.
Xv Han+4 more
doaj +1 more source
Terlipressin Infusion in Catecholamine-resistant Shock [PDF]
Catecholamine-resistant shock is not uncommon in intensive care. Bolus dose terlipressin (a vasopressin analogue) has been used successfully in this setting allowing cessation of other vasopressor agents. The relative vasopressin deficiency in combination with the restoration of the vascular tone (by blocking adenosine triphosphate potassium-sensitive
D. H. Jolley+3 more
openaire +3 more sources
Association of Anaesthetists guidelines: the use of blood components and their alternatives
Summary Background The administration of blood components and their alternatives can be lifesaving. Anaemia, bleeding and transfusion are all associated with poor peri‐operative outcomes. Considerable changes in the approaches to optimal use of blood components and their alternatives, driven by the findings of large randomised controlled trials and ...
Akshay Shah+12 more
wiley +1 more source
Early Dynamics of Portal Pressure Gradient After TIPS Insertion Predict Mortality
The lack of increase in portal pressure gradients (PPG) within 24 h after TIPS implantation is associated with poorer outcomes. ABSTRACT Background Transjugular intrahepatic portosystemic shunt (TIPS) placement leads to a reduction in portal pressure and an improvement in survival in patients with recurrent and refractory ascites and variceal ...
P. A. Reuken+14 more
wiley +1 more source
ABSTRACT Background Portal hypertension (PH) is a critical complication in patients with hepatic diseases. Its accurate evaluation is essential for early diagnosis, risk stratification, and management. Endoscopic ultrasound (EUS) has emerged as a promising diagnostic tool, offering high‐resolution imaging of the portal venous system, hepatic ...
Fabrizio Termite+6 more
wiley +1 more source